TimesSquare Capital Management LLC Has $17.28 Million Position in CeriBell, Inc. $CBLL

TimesSquare Capital Management LLC lowered its position in CeriBell, Inc. (NASDAQ:CBLL) by 3.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 787,926 shares of the company’s stock after selling 29,719 shares during the quarter. TimesSquare Capital Management LLC’s holdings in CeriBell were worth $17,279,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the company. CWM LLC increased its stake in shares of CeriBell by 1,178.5% in the fourth quarter. CWM LLC now owns 1,841 shares of the company’s stock valued at $40,000 after buying an additional 1,697 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of CeriBell by 353.8% in the second quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company’s stock valued at $43,000 after buying an additional 1,801 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in shares of CeriBell in the third quarter valued at approximately $33,000. Sei Investments Co. increased its stake in shares of CeriBell by 7.1% in the third quarter. Sei Investments Co. now owns 50,454 shares of the company’s stock valued at $580,000 after buying an additional 3,365 shares during the period. Finally, New York State Common Retirement Fund increased its stake in shares of CeriBell by 148.6% in the second quarter. New York State Common Retirement Fund now owns 8,700 shares of the company’s stock valued at $163,000 after buying an additional 5,200 shares during the period.

Analyst Ratings Changes

Several analysts recently commented on the company. Canaccord Genuity Group reduced their target price on CeriBell from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, May 12th. Weiss Ratings cut CeriBell from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, May 12th. Finally, BTIG Research reiterated a “buy” rating and issued a $30.00 target price on shares of CeriBell in a report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $22.20.

Insiders Place Their Bets

In other news, CTO Raymond Woo sold 11,112 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $18.56, for a total transaction of $206,238.72. Following the completion of the sale, the chief technology officer owned 166,912 shares of the company’s stock, valued at $3,097,886.72. This trade represents a 6.24% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Josef Parvizi sold 16,714 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $20.27, for a total transaction of $338,792.78. Following the sale, the director directly owned 722,652 shares of the company’s stock, valued at approximately $14,648,156.04. This trade represents a 2.26% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 175,119 shares of company stock valued at $3,310,772 over the last 90 days. 20.10% of the stock is owned by company insiders.

CeriBell Stock Performance

CBLL stock opened at $16.96 on Wednesday. The stock has a 50-day moving average price of $19.07 and a 200-day moving average price of $18.98. CeriBell, Inc. has a 1-year low of $10.85 and a 1-year high of $24.33. The company has a current ratio of 10.44, a quick ratio of 10.01 and a debt-to-equity ratio of 0.14. The firm has a market cap of $643.51 million, a PE ratio of -10.40 and a beta of 0.99.

CeriBell (NASDAQ:CBLL) last announced its quarterly earnings data on Monday, May 11th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.13). The business had revenue of $26.49 million during the quarter, compared to analyst estimates of $26.09 million. CeriBell had a negative net margin of 63.51% and a negative return on equity of 38.19%. As a group, equities research analysts expect that CeriBell, Inc. will post -1.69 earnings per share for the current year.

CeriBell Company Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.